1st Quarter - Report

COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC

Firm
Client
Income
$450,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269).

LobbyistCovered position, as disclosed
KRISTA CARVER —
NATALIE DERZKO —

Bills named: H.R. 6485 (119th), S. 43 (119th), S. 2276 (119th), H.R. 3269 (119th)

Health Issues HCR

Biosimilars Access and Affordability Act (S. 5459); Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269); Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954/H.R. 5526); CLEAR Act (H.R.7140); Artificial Intelligence-Ready Data Act (S.4098); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); Drug Competition Enhancement Act (S.1040); America's Living Library Project Bill (S. 4023); Securing Essential Components for U.S. Readiness in Essential Pharmaceuticals (SECURE Rx) Act of 2026 (discussion draft); improvements to the National Childhood Vaccine Injury Act of 1986; Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act (S. 3788).

LobbyistCovered position, as disclosed
KRISTA CARVER —
THOMAS COSGROVE New —
NATALIE DERZKO —
RICHARD F KINGHAM —
JENNIFER L PLITSCH —
MICHAEL STERN —

Contacted: SENATE

Bills named: S. 3788 (119th), S. 4098 (119th), S. 1040 (119th), H.R. 7140 (119th), S. 5459 (119th), S. 1954 (119th), H.R. 6485 (119th), H.R. 3269 (119th), S. 1414 (119th), H.R. 5526 (119th), S. 1096 (119th), S. 43 (119th), S. 2276 (119th), S. 4023 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.